Asia
QianJin Pharmaceutical, Unit Obtain China Approval for Three Drugs
China's drug regulator granted ZhuZhou QianJin Pharmaceutical (SHA:600479) and subsidiary Hunan Qianjin Xiangjiang Pharmaceutical drug registration certificates for dienogest tablets, potassium chloride granules, and ailamode tablets.Dienogest is indicated for endometriosis and could shrink ovarian endometriotic cysts, according to a Wednesday filing with the Shanghai bourse.Ailamode is indicated for active rheumatoid arthritis, while the potassium chloride granules help prevent and treat hypokalemia, or a lack of potassium in the blood, with or without metabolic alkalosis.
SHA:600479
